Unique ID issued by UMIN | UMIN000036402 |
---|---|
Receipt number | R000041469 |
Scientific Title | Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis |
Date of disclosure of the study information | 2019/04/04 |
Last modified on | 2019/12/06 14:17:28 |
Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis
Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in Japanese cypress pollinosis
Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis
Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in Japanese cypress pollinosis
Japan |
combined Japanese cedar and Japanese cypress pollinosis
Clinical immunology | Oto-rhino-laryngology |
Others
NO
Half of patients with combined Japanese cedar (JC) and Japanese cypress pollinosis have worsened symptoms after sublingual immunotherapy (SLIT) in cypress pollen season. Therefore, we examined the immunological effects of SLIT with standardized JC pollen extract in patients with combined JC and Japanese cypress pollinosis.
Efficacy
Confirmatory
Not applicable
Peripheral blood mononuclear cells (PBMCs) from patients with JC and Japanese cypress pollinosis who received SLIT with standardized JC pollen extract which was administered over a period of 1 to 2 years, were incubated with Cry j 1, Cha o 1 and Cha o 3 antigens. Antigen-induced production of IL-5, IL-10, IL-17 and IFN-g.
Serum concentrations of antigen-specific IgE and IgG4 were measured. A basophil activation test was also performed.
Observational
12 | years-old | <= |
Not applicable |
Male and Female
This prospective study included healthy controls, patients with combined JC and Japanese cypress pollinosis who were not treated with SLIT, and patients with combined pollinosis treated with SLIT.
The exclusion criteria were the presence or history of asthma or asthma-like symptoms.
120
1st name | Hirotaka |
Middle name | |
Last name | Kikuoka |
Shiga University of Medical Science
Department of Otorhinolaryngology
520-2192
Seta-tsukinowa, Otsu, Shiga 520-2192, Japan
0775482111
kikuoka@belle.shiga-med.ac.jp
1st name | Hirotaka |
Middle name | |
Last name | Kikuoka |
Shiga University of Medical Science
Department of Otorhinolaryngology
520-2192
Seta-tsukinowa, Otsu, Shiga 520-2192, Japan
0775482111
kikuoka@belle.shiga-med.ac.jp
Shiga University of Medical Science
This work was supported by Grant-in-Aid for Young Scientists, Japan.
Japanese Governmental office
Yuta Clinic
Shiga University of Medical Science
Seta-tsukinowa, Otsu, Shiga 520-2192, Japan.
075482111
rsupport@belle.shiga-med.ac.jp
NO
2019 | Year | 04 | Month | 04 | Day |
Published
127
Completed
2018 | Year | 03 | Month | 14 | Day |
2018 | Year | 03 | Month | 14 | Day |
2018 | Year | 03 | Month | 14 | Day |
2018 | Year | 12 | Month | 31 | Day |
Peripheral blood mononuclear cells (PBMCs) from patients with JC and Japanese cypress pollinosis who did (SLIT group) and did not (non-SLIT group) receive SLIT and from healthy controls were incubated with Cry j 1, Cha o 1 and Cha o 3 antigens. Antigen-induced production of IL-5, IL-10, IL-17 and IFN-g, and serum concentrations of antigen-specific IgE and IgG4 were measured. A basophil activation test was also performed.
2019 | Year | 04 | Month | 03 | Day |
2019 | Year | 12 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041469